Anti-Müllerian hormone (AMH) serves as a reliable blood marker of ovarian reserve, with clinical applications in PCOS diagnosis, IVF planning, and predicting menopause timing.
Strong correlation with ovarian reserveAMH blood levels reliably reflect the number of remaining eggs, making it the go-to biomarker for fertility assessment and IVF planning
What the researchers found
The review outlines AMH's key clinical roles:
• AMH is produced by granulosa cells of growing follicles before they become FSH-dependent, making it a direct marker of the ovarian follicle pool
• AMH serum concentration strongly correlates with ovarian reserve quantity and reflects ovulation potential
• In males, Sertoli cells produce high AMH levels that suppress Müllerian duct development during embryonic sex determination, maintaining high levels until puberty
• In females, AMH production begins in the second half of fetal life, declines through reproductive years, drops severely at menopause, and eventually becomes undetectable
• Clinical applications include PCOS diagnosis and pathogenesis assessment, artificial reproductive technology (IVF) planning, and prediction of menopause or premature ovarian failure
Why it matters
AMH testing has revolutionized reproductive medicine by giving women and their doctors objective data about fertility potential. Before AMH, assessing ovarian reserve required invasive procedures or less reliable markers. A simple blood test that predicts how many eggs remain — and how a woman will respond to IVF stimulation — empowers better family planning decisions and more personalized fertility treatment.
How the study worked
This is a narrative review published in the Journal of Clinical Medicine that synthesizes existing literature on AMH biology and clinical applications across reproductive medicine, embryology, and endocrinology.
What this study cannot tell us
As a narrative review, this presents a synthesis of existing knowledge rather than new data. AMH levels can vary between assay platforms, and interpretation requires clinical context — a single AMH level doesn't definitively determine fertility or infertility. The review doesn't address recent research on AMH-based contraception or AMH's potential roles beyond reproduction. Individual variability in AMH levels means population-level correlations don't always apply to individual patients.
How to read the evidence
This is a narrative review summarizing well-established clinical science on AMH. The clinical utility of AMH testing is supported by extensive evidence and is standard practice in reproductive medicine worldwide. The review itself does not generate new data.
When this study was published
Published in 2022, this review captures the current clinical consensus on AMH utility. AMH testing is well-established and the fundamental science hasn't changed significantly since publication.
The bigger picture
AMH sits at the intersection of peptide biology and reproductive medicine. As more women delay childbearing, understanding ovarian reserve has become a pressing clinical need. AMH testing is now standard practice in fertility clinics worldwide and is increasingly offered as part of routine women's health screening. The peptide's unique expression pattern — produced only by pre-selected follicles — makes it uniquely informative compared to other reproductive hormones like FSH or estradiol, which fluctuate throughout the menstrual cycle.
Questions still open
- Could AMH-targeted therapies be developed to extend the reproductive window or treat premature ovarian failure?
- How accurate is AMH alone versus combined biomarker panels for predicting IVF success?
- Should AMH testing be included in routine health screening for all women of reproductive age?
Common questions
What does an AMH blood test tell you about fertility?
Is AMH used to diagnose PCOS?
Read the original research
Clinical Utilities of Anti-Müllerian Hormone.
Journal of clinical medicine, 11(23)
Citation
Russell, Nicole; Gilmore, Andrea; Roudebush, William E. (2022). Clinical Utilities of Anti-Müllerian Hormone.. Journal of clinical medicine, 11(23). https://doi.org/10.3390/jcm11237209